ATE226068T1 - Antioxidantien - Google Patents

Antioxidantien

Info

Publication number
ATE226068T1
ATE226068T1 AT97920759T AT97920759T ATE226068T1 AT E226068 T1 ATE226068 T1 AT E226068T1 AT 97920759 T AT97920759 T AT 97920759T AT 97920759 T AT97920759 T AT 97920759T AT E226068 T1 ATE226068 T1 AT E226068T1
Authority
AT
Austria
Prior art keywords
pct
treatment
date nov
sec
prevention
Prior art date
Application number
AT97920759T
Other languages
English (en)
Inventor
Markku Ahotupa
Lauri Kangas
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of ATE226068T1 publication Critical patent/ATE226068T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT97920759T 1996-05-02 1997-05-02 Antioxidantien ATE226068T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9609171.5A GB9609171D0 (en) 1996-05-02 1996-05-02 Antioxidant compounds
PCT/FI1997/000266 WO1997041847A1 (en) 1996-05-02 1997-05-02 Antioxidant compounds

Publications (1)

Publication Number Publication Date
ATE226068T1 true ATE226068T1 (de) 2002-11-15

Family

ID=10793057

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920759T ATE226068T1 (de) 1996-05-02 1997-05-02 Antioxidantien

Country Status (12)

Country Link
US (2) US5929123A (de)
EP (1) EP0910354B1 (de)
JP (1) JP2000510114A (de)
AT (1) ATE226068T1 (de)
AU (1) AU709131B2 (de)
CA (1) CA2253230C (de)
DE (1) DE69716430T2 (de)
ES (1) ES2185935T3 (de)
GB (1) GB9609171D0 (de)
NO (1) NO323592B1 (de)
NZ (1) NZ332348A (de)
WO (1) WO1997041847A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9609171D0 (en) * 1996-05-02 1996-07-03 Orion Yhtymae Oy Antioxidant compounds
US6346547B1 (en) 1999-02-08 2002-02-12 Checkpoint, Genetics, Inc. N-substituted amino acids, antioxidant pharmaceutical compositions containing n-substituted amino acids and methods for preventing cardiovascular diseases and/or preventing and/or treating antioxidant responsive diseases therewith
KR100375159B1 (ko) * 2000-05-16 2003-03-08 김일한 팔미토일 보효소 ａ를 이용한 포유동물의 혈청알부민의 과산화효소 활성을 증가시키는 방법
US20070123490A1 (en) * 2005-11-30 2007-05-31 Yokoyama Wallace H Preventing or reducing oxidative stress or oxidative cell injury
EP2079476B1 (de) * 2006-10-20 2014-05-21 Dow Global Technologies LLC Verwendung hydroxypropylmethylcellulose zur vorbeugung oder behandlung des stoffwechselsyndroms
US20110130360A1 (en) * 2006-10-20 2011-06-02 Dow Global Technologies Inc. Preventing or reducing oxidative stress or oxidative cell injury
JP2009007256A (ja) * 2007-06-26 2009-01-15 Kao Corp Ｎａｄｈ／ｎａｄｐｈオキシダーゼ抑制剤
WO2011052804A1 (en) * 2009-10-30 2011-05-05 Tokyo University Of Science Educational Foundation Administrative Organization Method of delivering agent into target cell

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491173A (en) * 1982-06-25 1996-02-13 Orion-Yhtyma Oy Tri-phenyl alkene derivatives and their preparation and use
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
GB9207437D0 (en) * 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
DE4320896A1 (de) * 1993-06-24 1995-01-05 Denecke Rainer Dr Med Vet Präparat zur Therapie und Prophylaxe von Demenz-Erkrankungen
GB9418067D0 (en) * 1994-09-07 1994-10-26 Orion Yhtymae Oy Triphenylethylenes for the prevention and treatment of osteoporosis
GB9609171D0 (en) * 1996-05-02 1996-07-03 Orion Yhtymae Oy Antioxidant compounds

Also Published As

Publication number Publication date
NO323592B1 (no) 2007-06-11
NO985082D0 (no) 1998-10-30
JP2000510114A (ja) 2000-08-08
NO985082L (no) 1998-10-30
CA2253230C (en) 2007-03-13
DE69716430D1 (de) 2002-11-21
AU709131B2 (en) 1999-08-19
NZ332348A (en) 2000-05-26
ES2185935T3 (es) 2003-05-01
US5929123A (en) 1999-07-27
US6204295B1 (en) 2001-03-20
EP0910354A1 (de) 1999-04-28
CA2253230A1 (en) 1997-11-13
AU2702097A (en) 1997-11-26
DE69716430T2 (de) 2003-07-03
GB9609171D0 (en) 1996-07-03
EP0910354B1 (de) 2002-10-16
WO1997041847A1 (en) 1997-11-13

Similar Documents

Publication Publication Date Title
AR035963A1 (es) Compuestos derivados de trifluormetilbenceno utiles como intermedios de los inhibidores de la proteina de transferencia del ester de colesterilo y procedimientos para su preparacion
BR9815039A (pt) Inibição da oxidação de lipoproteìna
NO992769D0 (no) FremgangsmÕte for behandling og forhindring av hjertesvikt og ventricular dilasjon
PT944631E (pt) Novos derivados substituidos de pirazole para tratamento de doencas cardiovasculares
PT1049703E (pt) Aldeido do acido n-¬2-(5-benziloxicarbonilamino-6-oxo-2-(4-fluorofenil)-1,6-di-hidro-1-pirimidinil)acetoxil|-l-aspartico como inibidor da enzima de conversao da interleucina-1beta in vivo
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69716430D1 (de) Antioxidantien
DK0888327T3 (da) Benzopyranderivater, som har antagonistisk virkning imod leukotriener
DE69619865D1 (de) Aromatische keto-säure und ihre derivate als inhibitoren der matrix metalloproteinase
DE69726281D1 (de) Hemmstoff für die gefässneubildung, der den gewebefaktor-inhibitor (tfpi) enthält
RU96112829A (ru) Способ лечения ишемической болезни сердца
ES2164765T3 (es) Heterociclilbenzonitrilos.
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
DE69512940D1 (de) N-hydroxy-harnstoff-derivate als entzündunghemmende mittel
PT1334094E (pt) Benzo[b]tiofenos e benzo(d)isotiazoles para diminuir o colesterol
ATE218856T1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
DE69713648D1 (de) Benzopyranderivate und ihre Verwendung zur Behandlung von Herzkrankheiten
DK0426804T3 (da) 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzen-derivater
DE69124534D1 (de) Katecholderivate, deren physiologisch unbedenkliche Salze, Ester und deren Verwendung bei der Behandlung von durch Lipidperoxidation verursachten Gewebeschäden
IT9048173A0 (it) Apparecchiatura per il posizionamento e l'azionamento di strumenti chirurgici, in particolare per chirurgia corneale refrattiva, in particolare chirurgia refrattiva lamellare.
ID20165A (id) Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis
DE60024114D1 (de) Zusammensetzung zur behandlung von atherosklerose, welche ein statin und ex-vivo behandeltes blut enthält
ATE190845T1 (de) Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen
PE122199A1 (es) Polimorfos de dofetilida
NO903585L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0910354

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee